{
    "2015-10-16": [
        {
            "header": "Valeant subpoenaed by US prosecutors over drug pricing",
            "time": "7:21PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-subpoena-idUSL1N12F0LV20151015"
        },
        {
            "header": "Valeant subpoenaed by U.S. prosecutors; shares drop",
            "time": "7:20PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharms-subpoena-idUSKCN0S90XO20151015"
        },
        {
            "header": "IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Valeant Pharmaceuticals International, Inc. and Encourages Investors to Contact the Firm",
            "time": "5:51PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ca-goldberg-law-pc-idUSnBw156806a+100+BSW20151015"
        },
        {
            "header": "Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Synergetics USA, Inc.",
            "time": "5:00PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-synergetics-idUSnPn6MSZr0+9c+PRN20151015"
        },
        {
            "header": "CANADA STOCKS-TSX slips as energy stocks pull back, Valeant falls",
            "time": "4:49PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/markets-stocks-canada-idUSL1N12F2TO20151015"
        },
        {
            "header": "CANADA STOCKS-TSX ends down as energy stocks , Valeant weigh",
            "time": "4:12PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/markets-stocks-canada-open-idUSL1N12F2NZ20151015"
        },
        {
            "header": "GPM Commences Investigation on Behalf of Valeant Pharmaceuticals International Inc. Investors",
            "time": "3:11PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ca-glancy-prongay-murray-idUSnBw156596a+100+BSW20151015"
        },
        {
            "header": "VRX SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Valeant Pharmaceuticals International, Inc.",
            "time": "2:47PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ny-levi-korsinsky-idUSnBw156562a+100+BSW20151015"
        },
        {
            "header": "CANADA STOCKS-Resource retreat, Valeant subpoena push TSX lower",
            "time": "10:16AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/markets-stocks-canada-idUSL1N12F16420151015"
        },
        {
            "header": "SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Valeant Pharmaceuticals International, Inc.",
            "time": "10:01AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/bronstein-valeant-idUSnPn9LNXhB+9d+PRN20151015"
        },
        {
            "header": "CANADA STOCKS-TSX slips on resource retreat, Valeant subpoena",
            "time": "9:41AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/markets-stocks-canada-open-idUSL1N12F12E20151015"
        },
        {
            "header": "Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Synergetics USA, Inc.",
            "time": "8:45AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeantpharmaceutical-idUSnPn53hWfN+85+PRN20151015"
        }
    ],
    "2015-07-23": [
        {
            "header": "WeissLaw LLP: Unilens Vision, Inc. Acquisition By Valeant Pharmaceuticals International, Inc. May Not Be In The Best Interest Of UVIC Shareholders",
            "time": "3:06PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/weisslaw-unilens-idUSnPn5LKpdC+99+PRN20150722"
        }
    ],
    "2015-10-01": [
        {
            "header": "CANADA STOCKS-TSX ends up 2.1 percent; Valeant rebounds",
            "time": "4:11PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/markets-stocks-canada-close-idUSL1N12032B20150930"
        },
        {
            "header": "CANADA STOCKS-TSX rallies as Valeant rebounds, July GDP data upbeat",
            "time": "11:48AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/markets-stocks-canada-idUSL1N1201I520150930"
        },
        {
            "header": "CANADA STOCKS-TSX jumps soon after open on GDP data, Valeant rally",
            "time": "9:46AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/markets-stocks-canada-open-idUSL1N12010Z20150930"
        }
    ],
    "2014-05-30": [
        {
            "header": "Valeant boosts $53.8 billion Allergan bid as Ackman opts for stock",
            "time": "9:55PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/05/31/us-valeant-allergan-idUSKBN0EB02G20140531"
        },
        {
            "header": "CANADA STOCKS-TSX edges up with help from Valeant",
            "time": "5:02PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/05/30/markets-canada-stocks-idUSL1N0OG1Y620140530"
        },
        {
            "header": "Allergan Acknowledges Revised, Unsolicited Proposal from Valeant and Pershing Square",
            "time": "4:54PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/05/30/ca-allergan-idUSnBw305928a+100+BSW20140530"
        },
        {
            "header": "Valeant again boosts cash in offer for Allergan",
            "time": "2:48PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/05/30/valeant-allergan-idUSL1N0OG1QO20140530"
        },
        {
            "header": "Valeant And Pershing Square Make Revised Offer For Allergan Contingent On Good Faith Negotiations",
            "time": "2:36PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/05/30/vrx-allergan-offer-idUSnPn8S0tpD+91+PRN20140530"
        }
    ],
    "2015-04-30": [
        {
            "header": "Drugmaker Valeant raises forecasts, says CFO to leave ",
            "time": "10:32AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2015/04/29/us-valeant-pharms-results-idUSKBN0NK12820150429"
        },
        {
            "header": "Valeant Pharma posts profit, says CFO to step down",
            "time": "6:28AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2015/04/29/valeant-pharms-results-idUSL4N0XQ3BO20150429"
        },
        {
            "header": "Valeant Pharmaceuticals Reports First Quarter 2015 Financial Results",
            "time": "6:00AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2015/04/29/valeant-pharmaceutica-idUSnPn6yFNp2+8c+PRN20150429"
        },
        {
            "header": "Valeant Announces CFO Succession Plan And Additional Executive Appointment",
            "time": "6:00AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2015/04/29/valeantpharmaceutical-idUSnPn36HQp2+8c+PRN20150429"
        }
    ],
    "2015-10-02": [
        {
            "header": "Ackman's Pershing Square off 12.6 pct for year after Valeant tumble",
            "time": "11:48PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ackman-hedgefunds-returns-idUSL1N12204U20151002"
        }
    ],
    "2015-02-23": [
        {
            "header": "UPDATE 3-Canada's Valeant to acquire Salix in $10.1 billion deal",
            "time": "8:03PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2015/02/23/valeantpharms-salixpharms-idUSL1N0VW0MR20150223"
        },
        {
            "header": "Valeant to acquire Salix in $14.5 bln deal",
            "time": "4:52PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2015/02/22/valeantpharms-salixpharms-idUSASB097HI20150222"
        },
        {
            "header": "Valeant To Acquire Salix Pharmaceuticals For $158.00 Per Share In Cash",
            "time": "4:00PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2015/02/22/nc-valeant-to-acquire-idUSnPn9Tt4n1+90+PRN20150222"
        },
        {
            "header": "Valeant Pharmaceuticals Reports Fourth Quarter And Full Year 2014 Financial Results",
            "time": "4:00PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2015/02/22/valeant-q4-earnings-idUSnPn2R68Wj+92+PRN20150222"
        }
    ],
    "2011-08-04": [
        {
            "header": "RPT-UPDATE 4-Generic threat to Valeant drug sends shares reeling",
            "time": "3:06PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2011/08/04/valeant-idUSN1E77307620110804"
        },
        {
            "header": "Generic threat to Valeant drug sends shares reeling",
            "time": "3:01PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2011/08/04/us-valeant-idUSTRE7733E020110804"
        },
        {
            "header": "Valeant Pharmaceuticals Reports 2011 Second Quarter Financial Results",
            "time": "8:02AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2011/08/04/idUS147774+04-Aug-2011+PRN20110804"
        }
    ],
    "2012-05-03": [
        {
            "header": "Valeant shares fall as market cools on forecast",
            "time": "3:47PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2012/05/03/us-valeant-idUSBRE84218M20120503"
        },
        {
            "header": "UPDATE 1-Valeant raises forecast on acquisition boost",
            "time": "10:09AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2012/05/03/valeant-idUSL4E8G36YL20120503"
        },
        {
            "header": "Valeant posts quarterly loss on higher costs",
            "time": "8:20AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2012/05/03/valeant-idUSL4E8G35Q820120503"
        },
        {
            "header": "Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical",
            "time": "8:11AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2012/05/03/idUS138421+03-May-2012+PRN20120503"
        },
        {
            "header": "Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results",
            "time": "8:05AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2012/05/03/idUS136172+03-May-2012+PRN20120503"
        }
    ],
    "2015-08-05": [
        {
            "header": "CANADA STOCKS-TSX ends higher as Valeant offsets weakness in resources",
            "time": "4:33PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/markets-stocks-canada-close-idUSL1N10F30920150804"
        }
    ],
    "2015-10-23": [
        {
            "header": "Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Valeant Pharmaceuticals International, Inc.",
            "time": "10:00PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/robbins-valeant-idUSnPn74d8zy+80+PRN20151023"
        },
        {
            "header": "Valeant vows to refute 'phantom sales' allegations",
            "time": "8:40PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharms-canada-idUSKCN0SG1WJ20151023"
        },
        {
            "header": "Valeant slump poses big threat to small hedge funds",
            "time": "7:46PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-hedgefunds-idUSL1N12M3C820151022"
        },
        {
            "header": "UPDATE 3-Valeant vows to refute \"phantom sales\" allegations",
            "time": "6:04PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharmacies-idUSL1N12M1YD20151022"
        },
        {
            "header": "Valeant shares continue slide since Citron report",
            "time": "5:05PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharms-stocks-idUSKCN0SG1ZS20151022"
        },
        {
            "header": "TRLPC: Valeant\u2019s falling secondary loan price pulls pharma companies down",
            "time": "3:11PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-secondary-pharma-idUSKCN0SG2IB20151022"
        },
        {
            "header": "Valeant to host call to address, refute short-seller allegations",
            "time": "3:09PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-citron-conferencecall-idUSKCN0SG2I520151022"
        },
        {
            "header": "Valeant Pharmaceuticals To Hold Investor Conference Call On October 26, 2015",
            "time": "2:38PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/vrx-invester-confcall-idUSnPn3D2rBK+93+PRN20151022"
        },
        {
            "header": "Quebec regulator says claims against Valeant worrying; shares extend fall",
            "time": "2:25PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharmacies-idUSL1N12M1Y720151022"
        },
        {
            "header": "Valeant sets tone for post-M&A accounting scrutiny",
            "time": "12:22PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/idUS348013343620151022"
        },
        {
            "header": "INVESTIGATION REMINDER: Goldberg Law PC Announces an Investigation of Claims Against Valeant Pharmaceuticals International, Inc. and Encourages Investors to Contact the Firm",
            "time": "11:05AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ca-goldberg-law-idUSnBw226075a+100+BSW20151022"
        },
        {
            "header": "CANADA STOCKS-TSX rises with oil prices, even as Valeant drops again",
            "time": "11:03AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/canada-stocks-idUSL1N12M1RB20151022"
        },
        {
            "header": "CANADA STOCKS-TSX opens higher as energy shares gain; Valeant down 10 pct",
            "time": "9:39AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/canada-stocks-open-idUSL1N12M1H420151022"
        },
        {
            "header": "Specialty pharmacies in spotlight as Valeant ties questioned ",
            "time": "6:49AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharmacies-industry-idUSKCN0SG02320151022"
        }
    ],
    "2015-08-11": [
        {
            "header": "UVIC SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Unilens Vision Inc. Regarding the Sale of the Company to Valeant Pharmaceuticals International, Inc.",
            "time": "3:15PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ny-vincent-wong-idUSnBw106158a+100+BSW20150810"
        },
        {
            "header": "Active Equities to Watch in the Healthcare Sector -- AstraZeneca, Valeant Pharma, Novartis, Heron Therapeutics and Alkermes",
            "time": "9:15AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/bc-equity-research-insti-idUSnPn7yvmDK+83+PRN20150810"
        }
    ],
    "2015-10-27": [
        {
            "header": "VALEANT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Valeant Pharmaceuticals In",
            "time": "10:00PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/idUSnGNX7RdlVC+1d3+GNW20151027"
        },
        {
            "header": "TIMELINE-Deals, and doubts, mark Valeant's acquisition history",
            "time": "7:03PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharmacies-timeline-idUSL1N12N1PL20151026"
        },
        {
            "header": "Drugmaker Valeant raises detailed defense but doubts remain",
            "time": "6:57PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharmacies-idUSKCN0SK1FZ20151026"
        },
        {
            "header": "From pilot to profit-maker, Valeant's pharmacy rose quickly ",
            "time": "6:56PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharmacies-philidor-idUSKCN0SK2SB20151026"
        },
        {
            "header": "Valeant's defense does little to improve social media sentiment",
            "time": "6:38PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharmacies-socialmedia-idUSKCN0SK2P520151026"
        },
        {
            "header": " Controversial pharma CEO Martin Shkreli bails on Valeant bet",
            "time": "6:38PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharmacies-shkreli-idUSKCN0SK2RP20151026"
        },
        {
            "header": "Short interest piled on Valeant ahead of scathing report",
            "time": "6:37PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharmacies-shortinterest-idUSKCN0SK2RL20151026"
        },
        {
            "header": "UPDATE 1-Valeant bonds steady after analyst call",
            "time": "5:16PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-bonds-idUSL1N12Q29J20151026"
        },
        {
            "header": "CORRECTED-CANADA STOCKS-TSX falls 1.2 pct as resources slump, Valeant fails to reassure",
            "time": "5:15PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/canada-stocks-idUSL1N12Q2CV20151026"
        },
        {
            "header": "CANADA STOCKS-TSX falls more than 1 pct; resource stocks, Valeant weigh",
            "time": "4:04PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/canada-stocks-close-idUSL1N12Q23X20151026"
        },
        {
            "header": "IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against Valeant Pharmaceuticals International, Inc. and Encourages Investors to Contact the Firm",
            "time": "2:23PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ca-khang-khang-llp-idUSnBw266366a+100+BSW20151026"
        },
        {
            "header": "Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Valeant Pharmaceuticals International, Inc. Investors",
            "time": "2:13PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ca-glancy-prongay-murray-idUSnBw266355a+100+BSW20151026"
        },
        {
            "header": "Valeant\u2019s clarification efforts further tangle web",
            "time": "1:44PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/idUS251522720720151026"
        },
        {
            "header": "Valeant gets DOJ subpoena over Bausch & Lomb payments",
            "time": "1:13PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-subpoena-idUSL1N12Q1HR20151026"
        },
        {
            "header": "Valeant bonds steady after analyst call",
            "time": "12:34PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-bonds-idUSL1N12Q11Z20151026"
        },
        {
            "header": "CANADA STOCKS-TSX falls as resource stocks, Valeant weigh",
            "time": "10:35AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/canada-stocks-idUSL1N12Q13O20151026"
        },
        {
            "header": "CANADA STOCKS-TSX falls, weighed by resource stocks, Valeant",
            "time": "9:37AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/canada-stocks-open-idUSL1N12Q0YJ20151026"
        },
        {
            "header": "Statements Of J. Michael Pearson, Chairman And CEO, And Robert Ingram, Lead Outside Director Of Valeant Pharmaceuticals",
            "time": "9:00AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharmaceutica-idUSnPn3kxyJ1+82+PRN20151026"
        },
        {
            "header": "Valeant calls for SEC investigation into short-seller's actions",
            "time": "8:34AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharmacies-idUSL1N12Q0RK20151026"
        },
        {
            "header": "Hagens Berman Alerts Valeant (NYSE: VRX) Investors of Filed Securities Fraud Class Action",
            "time": "8:30AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/idUSnGNX2lnL1Y+1c5+GNW20151026"
        },
        {
            "header": "Valeant to set up panel to review link with specialty pharmacy",
            "time": "7:37AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharms-pricing-panel-idUSKCN0SK13J20151026"
        },
        {
            "header": "Valeant sets up panel to look into specialty pharmacy association",
            "time": "6:30AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-pricing-panel-idUSL3N12Q3LN20151026"
        },
        {
            "header": "Valeant Pharmaceuticals Confirms Appropriateness Of Accounting, Appoints Ad Hoc Board Committee To Review Philidor",
            "time": "6:15AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeantpharmaceutical-idUSnPnbLhQJ4+96+PRN20151026"
        },
        {
            "header": "Valeant Pharmaceuticals Announces The Addition Of G. Mason Morfit To Its Board Of Directors",
            "time": "6:00AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-personnel-idUSnPnQMzYJ+5b+PRN20151026"
        }
    ],
    "2015-11-04": [
        {
            "header": "Icahn nods at Valeant interest, pushes for cash repatriation law",
            "time": "6:50PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-icahn-activist-idUSKCN0SS2PI20151103"
        },
        {
            "header": "SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Valeant Pharmaceuticals International, Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Ac",
            "time": "5:25PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/md-brower-piven-idUSnBw037010a+100+BSW20151103"
        },
        {
            "header": "Valeant's crisis fuels feud between Ackman and Australian fund manager Hempton",
            "time": "10:09AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharmacies-ackman-idUSKCN0SS1QN20151103"
        }
    ],
    "2015-09-29": [
        {
            "header": "UPDATE 3-U.S. House Democrats slam Valeant's drug price hikes; shares sink",
            "time": "8:27PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-congress-idUSL1N11Y1PZ20150929"
        },
        {
            "header": "CANADA STOCKS-TSX slumps as resources weigh, Valeant tumbles",
            "time": "4:37PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/markets-stocks-canada-idUSL1N11Y2GF20150928"
        },
        {
            "header": "CANADA STOCKS-TSX slumps as Valeant tumbles, resource stocks weigh",
            "time": "4:04PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/markets-stocks-canada-close-idUSL1N11Y2C920150928"
        },
        {
            "header": "U.S. House Democrats take aim at price hikes for Valeant drugs; shares drop",
            "time": "1:49PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-congress-idUSL1N11Y1NS20150928"
        }
    ],
    "2013-05-24": [
        {
            "header": "CANADA STOCKS-Valeant deal sparks share jump, helps TSX ends week higher",
            "time": "4:58PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2013/05/24/markets-canada-stocks-idUSL2N0E51RN20130524"
        },
        {
            "header": "Valeant near deal to acquire Bausch & Lomb: source",
            "time": "4:16PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2013/05/24/us-valeant-bauschlomb-idUSBRE94N0PM20130524"
        },
        {
            "header": "UPDATE 3-Valeant near deal to acquire Bausch & Lomb -source",
            "time": "4:14PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2013/05/24/valeant-bauschlomb-idUSL2N0E513120130524"
        }
    ],
    "2016-01-14": [
        {
            "header": "Valeant Pharmaceuticals woos investors, stock dips",
            "time": "2:47PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-ceo-idUSL2N14X1JZ20160113"
        },
        {
            "header": "BRIEF-Valeant Pharmaceuticals says no update on CEO's health",
            "time": "1:58PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/idUSL2N14X1XQ20160113"
        }
    ],
    "2015-02-22": [
        {
            "header": "Valeant nears deal to buy Salix for about $10 billion: WSJ",
            "time": "4:25PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2015/02/21/us-salix-valeant-pharms-idUSKBN0LP0SG20150221"
        }
    ],
    "2014-01-07": [
        {
            "header": "CANADA STOCKS-Gains in energy shares, Valeant drive TSX higher",
            "time": "4:46PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/01/07/markets-canada-stocks-idUSL2N0KH23F20140107"
        },
        {
            "header": "CANADA STOCKS-TSX ends higher as Valeant, energy shares drive gain",
            "time": "4:06PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/01/07/markets-canada-stocks-closer-idUSL2N0KH21B20140107"
        },
        {
            "header": "UPDATE 2-Valeant aims to crack top drugmaker ranks through deals",
            "time": "12:11PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/01/07/valeant-outlook-idUSL2N0KH0VE20140107"
        },
        {
            "header": "CANADA STOCKS-Energy shares, drugmaker Valeant drive TSX higher",
            "time": "10:56AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/01/07/markets-canada-stocks-idUSL2N0KH14V20140107"
        },
        {
            "header": "CANADA STOCKS-TSX opens higher as Valeant jumps",
            "time": "9:39AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/01/07/markets-canada-stocks-opener-idUSL2N0KH10720140107"
        },
        {
            "header": "Valeant seeks to become top 5 pharmaceutical company -CEO",
            "time": "8:53AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/01/07/valeant-outlook-acquisitions-idUSL2N0KH0UC20140107"
        },
        {
            "header": "Valeant Pharmaceuticals sees 40 pct higher revenue, profit in 2014",
            "time": "8:20AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/01/07/valeant-outlook-idUSL2N0KH0T220140107"
        },
        {
            "header": "Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan",
            "time": "8:01AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/01/07/bc-analysts-corner-idUSnPn7zp0hn+80+PRN20140107"
        }
    ],
    "2015-09-30": [
        {
            "header": "CANADA STOCKS-TSX higher in choppy trading; Valeant, energy key movers",
            "time": "11:24AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/markets-stocks-canada-idUSL1N11Z1BP20150929"
        }
    ],
    "2015-10-30": [
        {
            "header": "U.S. antitrust enforcers could undo Valeant lens monopoly-lawyers",
            "time": "8:38PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-antitrust-lenses-idUSL1N12U00X20151030"
        },
        {
            "header": "CVS, Express Scripts drop Valeant's Philidor; stock dives",
            "time": "7:27PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharmacies-shareholders-idUSKCN0SN28U20151029"
        },
        {
            "header": "CVS Health drops Philidor, adds to Valeant's woes ",
            "time": "4:12PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharmacies-cvs-health-idUSKCN0SN2QY20151029"
        },
        {
            "header": "Largest shareholder urges Valeant to pay down debt",
            "time": "12:35PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharmacies-shareholders-idUSL3N12T5UX20151029"
        },
        {
            "header": "RPT-INSIGHT-Valeant's master plan for its contact lens business",
            "time": "7:00AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharmacies-lenses-idUSL1N12T0A120151029"
        },
        {
            "header": "Valeant's ambitious plan for its contact lens business",
            "time": "4:59AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharmacies-lenses-insight-idUSKCN0SN0CC20151029"
        }
    ],
    "2015-09-02": [
        {
            "header": "Valeant picks up AstraZeneca psoriasis drug after Amgen exit ",
            "time": "3:36AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharms-astrazeneca-deals-idUSKCN0R12TA20150901"
        },
        {
            "header": "Valeant gets right to develop AstraZeneca's psoriasis drug",
            "time": "2:28AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-astrazeneca-deals-idUSL4N1172LP20150901"
        },
        {
            "header": "Valeant And AstraZeneca To Partner On Brodalumab",
            "time": "2:00AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-astrazenica-idUSnPnbLhB8g+94+PRN20150901"
        }
    ],
    "2015-10-15": [
        {
            "header": "Valeant Provides Update Regarding Government Inquiries",
            "time": "9:13PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeantpharm-govt-idUSnPn8HXRmg+9c+PRN20151015"
        }
    ],
    "2015-07-24": [
        {
            "header": "Valeant profit beats estimates as U.S. sales stay strong",
            "time": "3:58PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharms-results-idUSKCN0PX1G620150723"
        },
        {
            "header": "Commonwealth Laboratories, Inc. Announces Agreement with Valeant Pharmaceuticals for the Acquisition of Commonwealth\u2019s U.S. and Canadian Business",
            "time": "7:00AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ma-commonwealth-labs-idUSnBw235551a+100+BSW20150723"
        },
        {
            "header": "Valeant Pharma revenue rises 34 pct",
            "time": "6:12AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-results-idUSL3N1033RN20150723"
        },
        {
            "header": "Valeant Pharmaceuticals Reports Second Quarter 2015 Financial Results",
            "time": "6:00AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-earns-idUSnPn4774Wn+82+PRN20150723"
        }
    ],
    "2016-02-29": [
        {
            "header": "Valeant CEO Pearson to return effective immediately, results delayed",
            "time": "9:10PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharms-ceo-idUSKCN0W204O"
        },
        {
            "header": "Valeant CEO Pearson to return effective immediately",
            "time": "7:53PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-ceo-idUSL2N16800W"
        }
    ],
    "2015-09-17": [
        {
            "header": "Valeant Pharmaceuticals Renews CeraVe\u00ae Partnership with USA Swimming as Exclusive Skincare Sponsor",
            "time": "8:30AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharmpartners-idUSnPn1B8z0l+90+PRN20150916"
        }
    ],
    "2014-01-08": [
        {
            "header": "CANADA STOCKS-TSX climbs as U.S. jobs data, Valeant support",
            "time": "4:53PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/01/08/markets-canada-stocks-idUSL2N0KI2CD20140108"
        },
        {
            "header": "CANADA STOCKS-TSX ends higher, driven by U.S. jobs data, Valeant",
            "time": "4:09PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/01/08/markets-canada-stocks-closer-idUSL2N0KI28K20140108"
        },
        {
            "header": "CANADA STOCKS-TSX rises slightly as Valeant continues advance",
            "time": "11:14AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/01/08/markets-canada-stocks-idUSL2N0KI1C220140108"
        },
        {
            "header": "Living Proof Enters into a Global Strategic Partnership with Valeant Pharmaceuticals in Aesthetic Dermatology",
            "time": "11:07AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/01/08/ma-living-proof-idUSnBw086110a+100+BSW20140108"
        },
        {
            "header": "CANADA STOCKS-TSX opens higher on U.S. jobs data, Valeant",
            "time": "9:42AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/01/08/markets-canada-stocks-opener-idUSL2N0KI14C20140108"
        }
    ],
    "2015-11-19": [
        {
            "header": "INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 From Investment in Valeant Pharmaceuticals International, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Ac",
            "time": "6:24PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/idUSnGNX2fbGWm+1c6+GNW20151118"
        },
        {
            "header": "Valeant to offer cash, stock to keep staff after turmoil",
            "time": "10:01AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharmacies-workers-idUSKCN0T724Q20151118"
        },
        {
            "header": "BRIEF-Valeant seeing 'anxiety' among US staff, will expand retention program - spokeswoman",
            "time": "9:03AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/idUSL1N13D0ZG20151118"
        }
    ],
    "2015-03-10": [
        {
            "header": "Valeant Announces Launch Of Private Offering Of Senior Notes",
            "time": "4:40PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2015/03/09/valeant-pharmaceutica-idUSnPn6ysyt3+80+PRN20150309"
        },
        {
            "header": "Exclusive: Ackman's Pershing Square makes $3.3 billion bet on Valeant",
            "time": "2:51PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2015/03/09/us-valeant-ackman-idUSKBN0M51PE20150309"
        },
        {
            "header": "Pershing Square Announces New Position in Valeant Pharmaceuticals International",
            "time": "1:41PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2015/03/09/ny-pershing-square-idUSnBw096213a+100+BSW20150309"
        }
    ],
    "2014-05-29": [
        {
            "header": "Sirona Biochem Expands Exclusive Skin Lightening License With Valeant Pharmaceuticals to Include AMBI and Kinerase",
            "time": "7:45AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/05/29/idUSnMKWjj2Jwa+1c4+MKW20140529"
        }
    ],
    "2015-10-22": [
        {
            "header": "Valeant plunge spotlights cracks in specialty pharma's M&A facade",
            "time": "9:09PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharmacies-rivals-idUSKCN0SG02L20151022"
        },
        {
            "header": "RPT-UPDATE 2-Valeant meltdown costs investors billions; Ackman ups stake",
            "time": "9:00PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-ackman-idUSL1N12L1SB20151022"
        },
        {
            "header": "Specialty pharmacies in spotlight as Valeant ties questioned",
            "time": "8:33PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharmacies-industry-idUSL1N12L3B720151022"
        },
        {
            "header": "Pershing Square Holdings, Ltd. Increases Position In Valeant Pharmaceuticals International",
            "time": "7:35PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/pershing-square-idUSnBw216824a+100+BSW20151021"
        },
        {
            "header": "Wall St. declines; Valeant, healthcare weigh ",
            "time": "6:34PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-markets-stocks-idUSKCN0SF18N20151021"
        },
        {
            "header": "US STOCKS-Wall St declines; Valeant, healthcare weigh",
            "time": "6:33PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/usa-stocks-idUSL1N12L35D20151021"
        },
        {
            "header": "Often criticized, Valeant's unusual CEO comes under heavy fire",
            "time": "5:34PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-citron-ceo-idUSKCN0SF2VV20151021"
        },
        {
            "header": "Valeant shares plunge on short-seller scrutiny of pharmacy revenue",
            "time": "5:34PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-citron-idUSKCN0SF22520151021"
        },
        {
            "header": "US STOCKS-Wall St falls; Valeant, healthcare drop",
            "time": "4:57PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/usa-stocks-idUSL1N12L2RM20151021"
        },
        {
            "header": "CANADA STOCKS-TSX falls 1 pct on Valeant plunge, resource slip",
            "time": "4:43PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/canada-stocks-idUSL1N12L2S720151021"
        },
        {
            "header": "CANADA STOCKS-TSX ends 1 pct lower as Valeant tumbles",
            "time": "4:14PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/canada-stocks-close-idUSL1N12L2JZ20151021"
        },
        {
            "header": "Citron's Left hits nerve with new Valeant broadside",
            "time": "3:08PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-citron-left-idUSKCN0SF2K020151021"
        },
        {
            "header": "Hedge fund mogul Ackman hit hard by huge Valeant bet",
            "time": "2:56PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-ackman-idUSKCN0SF2GC20151021"
        },
        {
            "header": "Valeant bonds plunge on short-seller report",
            "time": "2:49PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-citron-bonds-idUSL1N12L21T20151021"
        },
        {
            "header": "Sutts, Strosberg LLP Announces Investigation of Valeant Pharmaceuticals International Inc.",
            "time": "2:31PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/sutts-strosberg-llp-idUSnBw216492a+100+BSW20151021"
        },
        {
            "header": "Valeant Pharmaceuticals Responds To Erroneous Report",
            "time": "1:39PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharma-idUSnPn6bvXmZ+85+PRN20151021"
        },
        {
            "header": "INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Claims Against Valeant Pharmaceuticals International, Inc. and Advises Investors to Contact the Firm",
            "time": "1:11PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ca-khang-khang-llp-idUSnBw216379a+100+BSW20151021"
        },
        {
            "header": "Ackman's Valeant bet costs firm roughly $820 million on Wednesday",
            "time": "12:58PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-ackman-idUSL1N12L1QM20151021"
        },
        {
            "header": "EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Valeant Pharmaceuticals International, Inc. - VRX",
            "time": "12:19PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ny-rosen-law-firm-idUSnBw216278a+100+BSW20151021"
        },
        {
            "header": "CORRECTED-UPDATE 1-Valeant shares plunge on short-seller report",
            "time": "11:44AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-citron-idUSL1N12L19L20151021"
        },
        {
            "header": "INVESTOR ALERT: Investigation of Valeant Pharmaceuticals International, Inc. Announced by Law Offices of Howard G. Smith",
            "time": "11:40AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/pa-law-offc-howard-smith-idUSnBw216190a+100+BSW20151021"
        },
        {
            "header": "VALEANT SHAREHOLDER ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Valeant Pharmaceuticals International, Inc.; Encourages Investors to Contact the Firm",
            "time": "11:36AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ca-johnson-weaver-idUSnBw216181a+100+BSW20151021"
        },
        {
            "header": "IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of Claims Against Valeant Pharmaceuticals International, Inc. on Behalf of Investors",
            "time": "11:20AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ca-khang-khang-llp-idUSnBw216147a+100+BSW20151021"
        },
        {
            "header": "Valeant shares plunge on short-seller report",
            "time": "10:36AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-citron-idUSL1N12L16920151021"
        }
    ],
    "2015-10-20": [
        {
            "header": "Valeant CEO sees new drug pricing environment ahead",
            "time": "11:51PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharms-result-idUSKCN0SD11720151020"
        },
        {
            "header": "Valeant\u2019s platform trembles beneath Ackman\u2019s feet",
            "time": "6:18PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/idUS218796637020151019"
        },
        {
            "header": "CANADA STOCKS-TSX slips on retreat in resource stocks, Valeant",
            "time": "10:17AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/canada-stocks-idUSL1N12J0ZI20151019"
        },
        {
            "header": "Valeant seriously considering the sale of neuro assets",
            "time": "9:21AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharms-divestiture-idUSKCN0SD1JB20151019"
        },
        {
            "header": "BRIEF-Valeant CEO says is in touch with government on investigations",
            "time": "8:35AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/idUSL1N12J0O720151019"
        },
        {
            "header": "Strong dermatology product sales help Valeant top estimates",
            "time": "8:15AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharms-result-idUSKCN0SD11420151019"
        },
        {
            "header": "Valeant Pharma revenue rises 36 pct",
            "time": "6:08AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharms-result-idUSL3N12J3HQ20151019"
        },
        {
            "header": "Valeant Pharmaceuticals Reports Third Quarter 2015 Financial Results",
            "time": "6:00AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-earns-idUSnPn1BzDkf+94+PRN20151019"
        }
    ],
    "2015-10-21": [
        {
            "header": "VRX SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Valeant Pharmaceuticals International, Inc. -- V",
            "time": "5:09PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/levi-valeant-alert-idUSnPn5GXJ2d+9c+PRN20151020"
        },
        {
            "header": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX",
            "time": "3:17PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/pomerantz-valeant-idUSnPn4x75xH+81+PRN20151020"
        }
    ],
    "2015-08-26": [
        {
            "header": "Valeant Pharmaceuticals Announces The Addition Of D. Robert Hale To Its Board Of Directors",
            "time": "8:00AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-boardofdirect-idUSnPn9Tmrbf+90+PRN20150825"
        }
    ],
    "2015-10-28": [
        {
            "header": "Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Valeant Pharmaceuticals International, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit \u2013 VR",
            "time": "10:10PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/idUSnGNXbKmSrv+1d4+GNW20151028"
        },
        {
            "header": "FTC looking at Valeant's contact lens dealings -source",
            "time": "6:03PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharmacies-ftc-idUSL1N12R3KX20151027"
        },
        {
            "header": "SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class  Action Against Valeant Pharmaceuticals International, Inc. and Certain Officers -- VRX",
            "time": "5:59PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/idUSnGNX3bvGvY+1c5+GNW20151027"
        },
        {
            "header": "Ackman to hold call to discuss investment in Valeant",
            "time": "5:09PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeant-pharmacies-ackman-idUSKCN0SL1W520151027"
        },
        {
            "header": "ValueAct rallies Valeant investors as company fends off attack: source",
            "time": "5:09PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-valeantpharms-valueact-idUSKCN0SL2YZ20151027"
        },
        {
            "header": "Harwood Feffer LLP Announces Investigation of Valeant Pharmaceuticals International, Inc.",
            "time": "4:08PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/harwood-valeant-alert-idUSnPn4CvSFX+97+PRN20151027"
        },
        {
            "header": "Pershing Square Holdings, Ltd. Announces Investor Call to Discuss its Investment in Valeant Pharmaceuticals International, Inc.",
            "time": "6:00AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/pershing-square-idUSnBw275690a+100+BSW20151027"
        }
    ],
    "2011-08-03": [
        {
            "header": "/C O R R E C T I O N -- Valeant Pharmaceuticals International, Inc./",
            "time": "3:28PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2011/08/03/idUS226290+03-Aug-2011+PRN20110803"
        },
        {
            "header": "Valeant Pharmaceuticals Appoints Ronald Farmer to Fill Board Vacancy",
            "time": "8:01AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2011/08/03/idUS130248+03-Aug-2011+PRN20110803"
        }
    ],
    "2015-10-06": [
        {
            "header": "Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Synergetics USA, Inc.",
            "time": "5:00PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-synergetics-idUSnPn4P6QLx+96+PRN20151005"
        },
        {
            "header": "Valeant Pharmaceuticals To Announce 2015 Third Quarter Results On October 19, 2015",
            "time": "5:00PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-earns-call-idUSnPnbyxWvM+85+PRN20151005"
        }
    ],
    "2015-10-14": [
        {
            "header": "Seeger Weiss LLP Reports On Potential Congressional Subpoena Of Valeant Pharmaceuticals",
            "time": "7:09PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/seeger-weiss-reports-idUSnPn9FtHjS+95+PRN20151013"
        },
        {
            "header": "Valeant Pharmaceuticals Celebrates the Manufacturing of Four Billion Bottles of Eye Care Products at Bausch + Lomb's Greenville Solutions Plant",
            "time": "5:00PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant4billionbottle-idUSnPn4trR1C+85+PRN20151013"
        }
    ],
    "2015-10-29": [
        {
            "header": "VRX INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Valeant Pharmaceuticals International, Inc.",
            "time": "9:00AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ca-lieff-cabraser-idUSnBw285476a+100+BSW20151028"
        }
    ],
    "2016-03-15": [
        {
            "header": "CORRECTED-BRIEF-ValueAct's Ubben says Valeant CEO Pearson is right guy for job-CNBC",
            "time": "5:11PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeantpharmaceuticals-brief-idUSWNAB0ACDN"
        }
    ],
    "2015-11-05": [
        {
            "header": "Senate panel probing Valeant, Turing over drug costs",
            "time": "9:52PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-usa-congress-drugprices-idUSKCN0ST1S220151105"
        },
        {
            "header": "VRX INVESTORS ALERT: Lieff Cabraser Reminds Investors of Deadline in Securities Class Action Against Valeant Pharmaceuticals International, Inc.",
            "time": "5:19PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/ca-lieff-cabraser-idUSnBw046927a+100+BSW20151104"
        },
        {
            "header": "U.S. insurer caught on to odd billing at Valeant-linked pharmacy",
            "time": "12:41PM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/valeant-pharmacies-claims-idUSL1N12Z28M20151104"
        },
        {
            "header": "House oversight panel Democrats urge vote to subpoena Valeant, Turing",
            "time": "9:41AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/us-house-pharmaceuticals-probe-idUSKCN0ST1Z720151104"
        }
    ],
    "2014-03-06": [
        {
            "header": "Valeant Pharmaceuticals Donates $250,000 To The National Coalition Against Domestic Violence",
            "time": "10:00AM UTC",
            "body": "",
            "link": "http://www.reuters.com/article/2014/03/06/valeantpharma-donates-idUSnPnNYxQFmd+16c+PRN20140306"
        }
    ]
}